No, EVD is not an appropriate primary treatment for normal pressure hydrocephalus (NPH)
EVD serves only as a temporary diagnostic tool in NPH, not as primary treatment—permanent CSF diversion via ventriculoperitoneal shunt is the definitive therapy.
Why EVD is Not Primary Treatment for NPH
The evidence is clear that EVD has a fundamentally different role in NPH compared to acute hydrocephalus conditions:
Diagnostic Role Only
External ventricular drainage in NPH functions as a diagnostic test to predict shunt responsiveness, not as treatment itself 1, 2. The extended lumbar drainage (ELD) test—a related temporary CSF drainage procedure—helps identify patients who will benefit from permanent shunting, but has significant limitations with low negative predictive value 1, 3.
Definitive Treatment is Permanent Shunting
Ventriculoperitoneal shunt placement is the only proven effective therapy for NPH 2, 4, 5. The 2026 Chinese expert consensus and international guidelines consistently identify surgical shunting as the confirmed effective treatment, with EVD or lumbar drainage serving only as preoperative evaluation tools 4.
Key Evidence Distinguishing NPH from Acute Hydrocephalus
The guidelines you're seeing about EVD (6) specifically address aneurysmal subarachnoid hemorrhage (aSAH)-associated acute hydrocephalus—a completely different clinical entity from NPH. In aSAH, urgent CSF diversion via EVD is Class I recommendation to improve neurological outcome 6. This does not apply to NPH.
The Correct Approach for NPH
1. Clinical Diagnosis
- Classic triad: gait disturbance, urinary incontinence, cognitive impairment
- Imaging showing ventriculomegaly (Evans' index >0.3) with DESH pattern 2
- Differentiate from Parkinson's, Alzheimer's, and vascular dementia
2. Diagnostic Testing
- CSF tap test is the core preoperative evaluation 4, 5
- Extended lumbar drainage may be used but has limitations 1
- High positive predictive value (94-100%) but low negative predictive value (<50% except cognition) 3
3. Definitive Treatment
- Ventriculoperitoneal shunt with medium pressure valve 2, 3
- This is the only successful therapy proven to improve outcomes
- Early treatment is mandatory to prevent irreversible deficits 2
Critical Pitfall to Avoid
Do not confuse acute hydrocephalus management (where EVD is appropriate) with NPH management (where permanent shunting is required). EVD in NPH is purely a temporary diagnostic maneuver—typically 3-5 days of drainage to assess clinical response 7, 3. Even when 500mL is drained over 3 days, ventricular size barely changes (only 4.2% reduction), yet clinical improvement can occur, suggesting the benefit comes from repeated CSF removal rather than ventricular decompression 7.
Alternative Consideration
Recent systematic reviews suggest endoscopic third ventriculostomy (ETV) is generally not effective for NPH except possibly in a small subset with shorter symptom duration and better preoperative status 8. The current evidence does not support ETV as standard treatment for NPH.